Table 3.
Sociodemographic and Clinical Aspects in Correlation with Compliance
| Variables | Compliant N=20 (%) | Non-Compliant N=68 | Total | P value a |
|---|---|---|---|---|
| Gender | ||||
| Male | 19 (95%) | 59 (86.8%) | 78 (88.6%) | 0.270b |
| Female | 1 (5%) | 9 (13.2%) | 10 (11.4%) | |
| Age | ||||
| <60 | 11 (55%) | 12 (17.6%) | 23 (26.1%) | 0.001c |
| >60 | 9 (45%) | 56 (82.0%) | 65 (73.9%) | |
| Smoking | ||||
| Yes | 18 (90%) | 55 (80.9%) | 73 (83.0%) | 0.317b |
| No | 2 (20%) | 13 (19.1%) | 15 (17.0%) | |
| Family history | ||||
| Yes | 20 (100%) | 52 (76.5%) | 72 (81.8%) | 0.002b |
| No | 0 (0.0%) | 16 (23.5%) | 16 (18.2%) | |
| Co-morbidities | ||||
| 12 (60.0%) | 53 (77.9%) | 65 (73.9%) | 0.108c | |
| Delay of diagnosis | ||||
| (Within 2 weeks of presentation) | 16 (80.0%) | 47 (69.1%) | 63 (71.6%) | 0.002c |
| 4 (20.0%) | 21 (30.9%) | 25 (28.4%) | ||
| RR | ||||
| Yes | 11 (55.0%) | 63 (92.6%) | 74 (84.1%) | < 0.001c |
| No | 9 (45.0%) | 5 (7.4%) | 14 (15.9%) | |
| PR | ||||
| Yes | 1(5.3%) | 33 (54.1%) | 34(42.5) | < 0.001b |
| No | 18 (94.7%) | 28 (45.9%) | 46(57.5) | |
| MetsR | ||||
| Yes | 1(5.3%) | 23(37.7%) | 24(30.0%) | 0.003b |
| No | 18 (94.7%) | 38 (62.3%) | 56(70.0%) | |
| MR | ||||
| 0 (0.0%) | 16 (23.5%) | 16 (18.2%) | 0.002b |
Notes: aP values in bold are below the significance level of 0.05. bStatistical significance values calculated using Fisher’s Exact Test. cStatistical significance values calculated using the Pearson Chi-Square.
Abbreviations: RR, recurrence rate; PR, progression rate; MR, mortality rate.